Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Lucid Diagnostics Inc. LUCD
$1.50
+$0.01 (0.67%)
На 18:04, 12 мая 2023
+120.00%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
64222676.00000000
-
week52high
3.64
-
week52low
1.11
-
Revenue
377000
-
P/E TTM
-1
-
Beta
0.00000000
-
EPS
-1.66000000
-
Last Dividend
0.00000000
-
Next Earnings Date
14 мар 2023 г. в 12:30
Описание компании
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Needham | Buy | Buy | 16 авг 2022 г. |
| Needham | Buy | Buy | 12 мая 2022 г. |
| Needham | Buy | Buy | 29 мар 2022 г. |
| Canaccord Genuity | Buy | Buy | 29 мар 2022 г. |
| Ascendiant Capital | Buy | 27 дек 2021 г. | |
| Needham | Buy | Buy | 15 ноя 2022 г. |
| BTIG | Buy | Buy | 18 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sparks Ronald M | A | 175000 | 175000 | 31 янв 2023 г. |
| Cox James L | A | 175000 | 175000 | 31 янв 2023 г. |
| Lapidus Stanley | A | 175000 | 175000 | 31 янв 2023 г. |
| SOKOLOV JACQUE J | A | 175000 | 175000 | 31 янв 2023 г. |
| White Debra | A | 175000 | 175000 | 31 янв 2023 г. |
| PAVmed Inc. | A | 42483475 | 1479326 | 30 ноя 2022 г. |
| PAVmed Inc. | A | 41004149 | 331210 | 30 ноя 2022 г. |
| PAVmed Inc. | A | 40672939 | 221952 | 30 ноя 2022 г. |
| PAVmed Inc. | A | 40450987 | 197656 | 30 ноя 2022 г. |
| PAVmed Inc. | A | 40253331 | 1145086 | 30 ноя 2022 г. |
Новостная лента
Lucid Diagnostics Inc. (LUCD) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 21:50
Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Adrian Miller - Vice President-Investor Relations Lishan Aklog - Chairman & Chief Executive Officer Dennis McGrath - Chief Financial Officer Conference Call Participants Mike Matson - Needham & Company Ross Osborn - Cantor Fitzgerald Ed Woo - Ascendiant Capital Greetings, and welcome to Lucid Diagnostics Third Quarterly Update Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022
Business Wire
02 ноя 2022 г. в 08:25
NEW YORK--(BUSINESS WIRE)-- #CheckYourFoodTube--Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, a majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ), today announced that the Company will host a business update conference call and webcast on Monday, November 14, 2022, at 4:30 PM EDT.
Lucid Diagnostics Inc. (LUCD) CEO Lishan Aklog on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
15 авг 2022 г. в 21:57
Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Adrian Miller - Vice President-Investor Relations Lishan Aklog - Chairman & Chief Executive Officer Dennis McGrath - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Mike Matson - Needham & Company Ed Woo - Ascendiant Capital Mark Massaro - BTIG Operator Greetings, and welcome to Lucid Diagnostics Second Quarter 2020 Business Update Conference Call. At this time, all participants are in a listen-only mode.
Lucid Diagnostics to Hold a Business Update Conference Call on August 15, 2022
Business Wire
01 авг 2022 г. в 08:25
NEW YORK--(BUSINESS WIRE)---- $LUCD #businessupdate--Lucid Diagnostics Inc. announced that the Company will host a business update conference call on Monday, August 15, 2022, at 4:30 PM EDT.
Lucid Diagnostics' (LUCD) CEO Lishan Aklog on Q1 2022 Results - Earnings Call Transcript
Seeking Alpha
11 мая 2022 г. в 21:18
Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Adrian Miller – Vice President-Investor Relations Lishan Aklog – Chairman and Chief Executive Officer Dennis McGrath – Chief Financial Officer Conference Call Participants Ross Osborn – Cantor Fitzgerald Ed Woo – Ascendiant Capital Kyle Mikson – Canaccord Operator Greetings, welcome to the Lucid Diagnostics Business Update Conference Call. At this time, all participants are in a listen-only mode.